Mother-to-Child Transmission of HIV Infection in the Era of Highly Active Antiretroviral Therapy
Author(s) -
European Collaborative Study
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/427287
Subject(s) - medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , transmission (telecommunications) , virology , antiretroviral agents , sida , intensive care medicine , pediatrics , viral disease , viral load , immunology , electrical engineering , engineering
Very low rates of mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV) are achievable with use of highly active antiretroviral therapy (HAART). We examine risk factors for MTCT in the HAART era and describe infants who were vertically infected, despite exposure to prophylactic MTCT interventions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom